LifeMD, Inc. (LFMD)
2.955
-0.14
(-4.37%)
USD |
NASDAQ |
Sep 09, 16:00
2.955
0.00 (0.00%)
After-Hours: 18:10
LifeMD Enterprise Value : 128.64M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 128.64M |
| September 04, 2026 | 128.16M |
| September 03, 2026 | 126.73M |
| September 02, 2026 | 127.68M |
| September 01, 2026 | 129.12M |
| August 31, 2026 | 128.64M |
| August 28, 2026 | 131.03M |
| August 27, 2026 | 136.77M |
| August 26, 2026 | 135.81M |
| August 25, 2026 | 136.29M |
| August 24, 2026 | 131.03M |
| August 21, 2026 | 139.16M |
| August 20, 2026 | 137.73M |
| August 19, 2026 | 143.47M |
| August 18, 2026 | 137.25M |
| August 17, 2026 | 139.64M |
| August 14, 2026 | 145.86M |
| August 13, 2026 | 146.33M |
| August 12, 2026 | 138.20M |
| August 11, 2026 | 142.51M |
| August 10, 2026 | 153.99M |
| August 07, 2026 | 151.12M |
| August 06, 2026 | 143.47M |
| August 05, 2026 | 156.86M |
| August 04, 2026 | 167.38M |
| Date | Value |
|---|---|
| August 03, 2026 | 159.25M |
| July 31, 2026 | 148.25M |
| July 30, 2026 | 154.94M |
| July 29, 2026 | 154.94M |
| July 28, 2026 | 164.51M |
| July 27, 2026 | 165.94M |
| July 24, 2026 | 158.29M |
| July 23, 2026 | 165.94M |
| July 22, 2026 | 166.42M |
| July 21, 2026 | 176.46M |
| July 20, 2026 | 187.46M |
| July 17, 2026 | 179.33M |
| July 16, 2026 | 196.07M |
| July 15, 2026 | 197.50M |
| July 14, 2026 | 196.55M |
| July 13, 2026 | 208.50M |
| July 10, 2026 | 202.76M |
| July 09, 2026 | 207.07M |
| July 08, 2026 | 205.15M |
| July 07, 2026 | 214.24M |
| July 06, 2026 | 215.67M |
| July 02, 2026 | 213.76M |
| July 01, 2026 | 197.98M |
| June 30, 2026 | 178.37M |
| June 29, 2026 | 171.32M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biotricity, Inc. | 32.43M |
| Aclarion, Inc. | -10.30M |
| Establishment Labs Holdings, Inc. | 2.436B |
| Agilent Technologies, Inc. | 43.60B |
| Abbott Laboratories | 210.25B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.084M |
| Revenue (Quarterly) | 47.28M |
| Total Expenses (Quarterly) | 54.36M |
| EPS Diluted (Quarterly) | -0.1645 |
| Gross Profit Margin (Quarterly) | 79.67% |
| Profit Margin (Quarterly) | -14.98% |
| Earnings Yield | -17.47% |
| Normalized Earnings Yield | -16.88 |